CAM
ARNA

Connacht Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Connacht Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,320
Closed -$1.45M – 138
2021
Q3 		$1.45M Buy
24,320
+1,362
+6% +$80.5K 0.94% 34
2021
Q2 		$1.57M Sell
22,958
-12,050
-34% -$786K 0.67% 44
2021
Q1 		$2.43M Buy
35,008
+13,187
+60% +$1.01M 0.54% 51
2020
Q4 		$1.68M Buy
+21,821
New +$1.64M 0.8% 43

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Connacht Asset Management's ARNA Position: Q4 2021 in Review

Connacht Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 24,320 shares — an estimated $1.45M sold.

Connacht Asset Management first reported a position in ARNA in Q4 2020 and held it in 4 quarters. The position peaked at $2.43M in Q1 2021. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Connacht Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Connacht Asset Management sold 24,320 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $1.45M.
  • Connacht Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 4 quarters.
  • Connacht Asset Management's Arena Pharmaceuticals Inc position peaked at $2.43M in Q1 2021.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Connacht Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.